Trexquant Investment LP Purchases New Holdings in Teleflex Incorporated (NYSE:TFX)

Trexquant Investment LP acquired a new position in Teleflex Incorporated (NYSE:TFX) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 23,394 shares of the medical technology company’s stock, valued at approximately $4,164,000. Trexquant Investment LP owned 0.05% of Teleflex at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in TFX. Headlands Technologies LLC bought a new stake in shares of Teleflex during the 4th quarter worth approximately $29,000. Avior Wealth Management LLC increased its stake in Teleflex by 81.2% in the fourth quarter. Avior Wealth Management LLC now owns 279 shares of the medical technology company’s stock worth $50,000 after purchasing an additional 125 shares during the period. IFP Advisors Inc lifted its position in shares of Teleflex by 238.5% during the fourth quarter. IFP Advisors Inc now owns 308 shares of the medical technology company’s stock worth $55,000 after purchasing an additional 217 shares during the last quarter. Exchange Traded Concepts LLC boosted its stake in shares of Teleflex by 38.2% during the fourth quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company’s stock valued at $61,000 after purchasing an additional 94 shares during the period. Finally, R Squared Ltd bought a new position in shares of Teleflex in the fourth quarter worth about $64,000. Institutional investors own 95.62% of the company’s stock.

Teleflex Stock Down 4.4 %

NYSE:TFX opened at $131.93 on Friday. The stock has a market capitalization of $6.12 billion, a P/E ratio of 26.23, a P/E/G ratio of 1.73 and a beta of 1.19. Teleflex Incorporated has a fifty-two week low of $128.55 and a fifty-two week high of $249.91. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. The company’s 50-day simple moving average is $154.86 and its 200-day simple moving average is $186.65.

Teleflex (NYSE:TFX) last issued its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, topping the consensus estimate of $3.86 by $0.03. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The business had revenue of $795.40 million during the quarter, compared to the consensus estimate of $813.24 million. On average, equities analysts anticipate that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Friday, March 7th were paid a dividend of $0.34 per share. The ex-dividend date of this dividend was Friday, March 7th. This represents a $1.36 annualized dividend and a yield of 1.03%. Teleflex’s payout ratio is presently 95.77%.

Wall Street Analysts Forecast Growth

TFX has been the topic of a number of research analyst reports. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research note on Wednesday, March 12th. Truist Financial dropped their price objective on Teleflex from $200.00 to $149.00 and set a “hold” rating on the stock in a research note on Monday, March 3rd. StockNews.com lowered Teleflex from a “buy” rating to a “hold” rating in a research report on Friday, February 28th. Wells Fargo & Company dropped their price target on Teleflex from $214.00 to $146.00 and set an “equal weight” rating on the stock in a research report on Friday, February 28th. Finally, Royal Bank of Canada downgraded Teleflex from an “outperform” rating to a “sector perform” rating and decreased their price objective for the company from $220.00 to $155.00 in a report on Friday, February 28th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $182.63.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.